🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareNovo Nordisk CagriSema Phase 3 results — amylin + GLP-1 Page 3

Novo Nordisk CagriSema Phase 3 results — amylin + GLP-1

TrialTracker_MD Wed, Mar 11, 2026 at 4:45 AM 14 replies 338 viewsPage 3 of 3
Admin
Administrator
2,456
9,812
Oct 2023
Online
Mar 11, 2026 at 9:00 AM#11

Moderator note: Great discussion, everyone. Just a reminder to keep things civil and evidence-based.

Thread quality is excellent — keep it up. 👍

Last edited: Mar 11, 2026 at 1:00 PM
2 1PedsEndoPhilly, SleepDoc_PDX
Reply Quote Save Share Report
Dr.BariatricHTX
Senior Member
1,456
7,234
Feb 2024
Houston, TX
Mar 11, 2026 at 9:17 AM#12

Slightly tangential to Novo Nordisk CagriSema but Dr.NateNeph reminded me — has the insurance landscape changed recently?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

35 9pete_RVA, CarlaRPh_TPA, steph_laguna and 32 others
Reply Quote Save Share Report
TinaHashiRN
Member
345
1,567
Sep 2024
Raleigh, NC
Mar 11, 2026 at 9:34 AM#13
quinn_sf said:
Follow-up question: what labs did your doctor order to monitor this

This is exactly right. quinn_sf articulated what I have been trying to explain to my friends for months. The Novo Nordisk CagriSema aspect is what made the difference for me.

30 4Dr.Martinez, mike_mod, SarahChen_PharmD and 27 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
kevin_tulsa
Member
489
2,123
Jun 2024
Tulsa, OK
Mar 11, 2026 at 9:51 AM#14

Saving this for reference. Quality thread.

46 0quinn_sf, NurseLeah_Nash, gary_naperville and 43 others
Reply Quote Save Share Report
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Mar 11, 2026 at 10:08 AM#15

Adding my data to this Novo Nordisk CagriSema discussion:

MetricBaselineMonth 5Month 6
Weight240 lbs245 lbs215 lbs
A1C6.4%6.0%5.2%
hsCRP4.04.00.6

Protocol: Semaglutide 1.7mg/wk, resistance training 3x/wk, protein 1.2g/kg/day.

Last edited: Mar 11, 2026 at 11:08 AM
17 0mike_nyc, VendorMark, COA_Karl and 14 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register